22 results
PRE 14A
STOK
Stoke Therapeutics Inc
17 Apr 23
Preliminary proxy
4:01pm
during the fiscal year ended December 31, 2022 raised any conflict of interest.
Nominating and Corporate Governance Committee
Our Nominating … to review such transaction due to a conflict of interest. The policy provides that any request for us to enter into a transaction with an executive
S-3
EX-3.2
6te6s oig0gv
10 Jul 20
Shelf registration
4:06pm
S-3
EX-4.4
g0z 24t2gta
10 Jul 20
Shelf registration
4:06pm
424B4
scxuh9dw 1k
19 Jun 19
Prospectus supplement with pricing info
4:16pm
S-1/A
fhlhvd0 j9
7 Jun 19
IPO registration (amended)
6:08am
S-1/A
EX-10.1
ayr ybsslxky
7 Jun 19
IPO registration (amended)
6:08am
S-1
EX-3.4
97e7dnguc
23 May 19
IPO registration
4:02pm
S-1
EX-4.2
wg8dq3
23 May 19
IPO registration
4:02pm
S-1
v8chl78j3n5bzeog
23 May 19
IPO registration
4:02pm
S-1
EX-10.10
7la8o1wkqv5t
23 May 19
IPO registration
4:02pm
DRS/A
uigevs1
30 Apr 19
Draft registration statement (amended)
12:00am